LYVE1 and breast cancer: LYVE-1+ macrophages in the BC tumor microenvironment may affect tumor progression and immune responses through multiple mechanisms, such as forming multicellular nesting structures, inducing immunosuppression, and influencing tumor angiogenesis and metastasis (21).